A new peer-reviewed paper published in an Australian journal examining the top 10 myths about fitting soft contact lenses offers evidence to dispel common misconceptions held by eyecare practitioners. Read more
Study: Third of nAMD patients safely stopped eye injections
A new study has shown up to a third of neovascular age-related macular degeneration (nAMD) patients may safely be able to stop intravitreal injections after a year, while also highlighting a potential biomarker to identify the best candidates. Read more
Specsavers unveils AU$110 million investment for Canada expansion plans
Specsavers has announced it will invest AU$110 million to cover the full clinic and optical store start-up costs for new partners as the company pursues its first foray into the North American market. Read more
Glaukos trials eyelid cream to treat presbyopia and dry eye
Glaukos has commenced Phase 2 trials of two investigational cream-based drug candidates that are applied to the eyelids to treat dry eye and presbyopia. Read more
Preschool mobility and motor skills closely aligned with good vision, study shows
Abnormal motor skills in toddlers such as grasping may be associated with poorer vision when they reach preschool age, a new study involved South Australian researchers has revealed. Read more
Eyecare spin-off Bausch + Lomb files for IPO
Almost 18 months since its parent company announced Bausch + Lomb (B+L) would be spun off as a pure-play eye health company, the entity has filed for an initial public offering (IPO) on the New York and Toronto stock exchanges. Read more
Mojo Vision eyes fitness wearables market with smart contact lens
Smart contact lens startup Mojo Vision has signed strategic partnerships with leading sports and fitness brands. The company says it has identified an opportunity in the wearables market to deliver real-time performance data to athletes through its hands-free, eye-controlled user interface. Read more
Novartis targets GA gene therapy in Gyroscope Therapeutics deal
Novartis has announced it is acquiring Gyroscope Therapeutics, the UK-based company behind an investigational dry ADM gene therapy that is the focus of key clinical trials in Australia. Read more
Aussie-based authors among CORE’s top-tier papers; Dr Alex Hui appointed head of biosciences
Australian-based academics are among the authors of the most valuable scientific and clinical educational papers published by the Centre for Ocular Research and Education (CORE) in 2021. Read more
Clinical trial of molecule to treat microbial keratitis in pipeline
Researchers in the US have published a major breakthrough in understanding how to heal a cornea infected with microbial keratitis. Read more